Xeber.world
Biogen’s experimental Alzheimer’s drug diranersen reduced tau levels in early-stage patients and slowed cognitive decline in a Phase 2 trial. Meanwhil...
The pharmaceutical industry is calling for the next FDA commissioner to restore stability after months of turmoil, including leadership changes and st...
NASA's decades-long research on microgravity's impact on drug development has accelerated with the International Space Station. Discover how space-bas...
Vertex Pharma halts early-stage mRNA cystic fibrosis therapy VX-522 due to tolerability issues. Cytokinetics’ Myqorzo meets dual efficacy goals in gen...
A recent court ruling reinstated in-person dispensing requirements for mifepristone, challenging the FDA's regulatory authority. The Supreme Court tem...
The U.S. Supreme Court heard arguments on 'skinny labeling' in a case involving Amarin and Hikma Pharmaceuticals. Meanwhile, AstraZeneca announced a $...
The average drug takes a decade to reach the market due to inefficiencies in clinical trials. FDA Commissioner Robert Califf highlights that 45% of th...
Kelonia Therapeutics transformed from a struggling biotech startup into a $3 billion company. Discover how BioAge’s inflammation-focused strategy and...
BioAge Labs announced that its investigational cardiovascular pill, BGE-102, reduced inflammation by 85% in a Phase 1 study of obese patients. The red...